Athena Diagnostics, Inc.
🏢 View company profile →22Patents
14Active
22Granted
39Portfolio score
Filing activity: Jun 5, 1996 → Aug 31, 2020 · 6 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7119186B2 | Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH) | Chemistry; Metallurgy | 4 | Expired |
| US7704691B2 | Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2) | Chemistry; Metallurgy | 4 | Active |
| US6916619B2 | Compositions and methods for genetic analysis of polycystic kidney disease | Chemistry; Metallurgy | 4 | Expired |
| US7273701B2 | Compositions and methods for genetic analysis of polycystic kidney disease | Chemistry; Metallurgy | 4 | Expired |
| US5691144A | Methods of detecting novel mutations relating to X-linked Charcot-Marie-Tooth disease | Chemistry; Metallurgy | 3 | Expired |
| US6001576A | Mutations relating to X-linked charcot-marie-tooth disease | Chemistry; Metallurgy | 2 | Expired |
| US8785122B2 | Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2) | Chemistry; Metallurgy | 2 | Active |
| US7521190B2 | Compositions and methods for genetic analysis of polycystic kidney disease | Chemistry; Metallurgy | 2 | Active |
| US7824860B2 | Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH) | Chemistry; Metallurgy | 2 | Active |
| US8192933B2 | Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2) | Chemistry; Metallurgy | 2 | Active |
| US6824999B1 | Detection of antibodies to gangliosides using solid-phase reactants coated with carbonyl groups | Physics | 1 | Expired |
| US6599756B1 | Detection of antibodies to glycosphingolipids using solid-phase reactants coated with carbonyl groups | Emerging Cross-Sectional Technologies | 1 | Expired |
| US10697016B2 | Methods to detect a silent carrier genotype | Chemistry; Metallurgy | 0 | Active |
| US9611512B2 | Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2) | Chemistry; Metallurgy | 0 | Active |
| US10762981B2 | Pathogenicity scoring system for human clinical genetics | Emerging Cross-Sectional Technologies | 0 | Active |
| US10227650B2 | Methods to detect a silent carrier of a null allele genotype | Chemistry; Metallurgy | 0 | Active |
| US7799529B2 | Nephrin gene and protein | Emerging Cross-Sectional Technologies | 0 | Active |
| US10760128B2 | PKD mutations and evaluation of same | Chemistry; Metallurgy | 0 | Active |
| US11655508B2 | PKD mutations and evaluation of same | Chemistry; Metallurgy | 0 | Active |
| US11512352B2 | Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2) | Chemistry; Metallurgy | 0 | Active |
| US8771946B2 | PKD mutations and evaluation of same | Chemistry; Metallurgy | 0 | Active |
| US6951763B2 | Detection of antibodies to glycosphingolipids using solid-phase reactants coated with carbonyl groups | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.